Covis Pharma

FDA forces unproven premature birth drug Makena off market
The Hill
Thu, 04/6/23 - 11:40 am
Makena
premature birth
Covis Pharma
FDA
FDA decision on preterm birth drug’s withdrawal nears, putting spotlight on patients, agency
BioPharma Dive
Mon, 03/6/23 - 11:37 pm
FDA
Makena
preterm birth
Covis Pharma
Adcomm again votes to pull controversial pre-term birth drug from the market
Endpoints
Wed, 10/19/22 - 01:20 pm
FDA
Covis Pharma
Makena
preterm birth
FDA opens case to withdraw controversial drug for preterm births
BioPharma Dive
Mon, 10/17/22 - 11:20 pm
FDA
Makena
Covis Pharma
preterm birth
FDA Review: Phanes, Pfizer, GSK and More
BioSpace
Fri, 10/14/22 - 10:38 am
FDA
Phanes
Pfizer
GSK
Regeneron
Eagle Pharmaceuticals
Galactin Therapeutics
BridgeBio
Gilead Sciences
Covis Pharma
scPharmaceuticals
XACT Robotics
BioMind Labs
Covis' controversial Makena gets FDA hearing date in bid to stay on the market
Fierce Pharma
Wed, 06/15/22 - 07:16 pm
Makena
Covis Pharma
FDA
preterm birth
FDA plots multi-day hearing to review 'dangling' accelerated approval that drugmaker refuses to pull
Endpoints
Sat, 04/23/22 - 03:50 pm
FDA
accelerated approvals
Covis Pharma
FDA lawyer digs in her heels as Makena accelerated approval withdrawal saga drags on
Endpoints
Wed, 04/20/22 - 10:54 am
Covis Pharma
Makena
FDA
preterm birth
Premature birth drug saga drags on as Covis questions fairness of FDA hearing
Endpoints
Wed, 02/9/22 - 10:17 am
Makena
Covis Pharma
FDA
premature birth
AstraZeneca Purges Two Respiratory Medicines in Big Day for Covis
BioSpace
Mon, 11/1/21 - 11:17 pm
AstraZeneca
COPD
Covis Pharma
Respiratory
Covis granted FDA hearing in latest twist over controversial premature-birth med Makena
Fierce Pharma
Fri, 08/20/21 - 12:25 pm
Covis Pharma
Makena
preterm birth
FDA
FDA puts its foot down on Makena: New meta-analysis does not change call to pull the drug
Endpoints
Mon, 03/29/21 - 10:39 am
Makena
FDA
premature birth
Covis Pharma
AstraZeneca divests asthma and rhinitis drug rights to Covis Pharma
Pharmaceutical Business Review
Thu, 12/6/18 - 11:33 pm
AstraZeneca
Covis Pharma
asthma
AstraZeneca Unloads Three Asthma and Rhinitis Drugs to Covis Pharma for $350 Million
BioSpace
Tue, 11/6/18 - 11:46 am
AstraZeneca
asthma
rhinitis
Covis Pharma
Alvesco
Omnaris
Zetonna
Sunovion divests asthma, allergy tech to Covis Pharma
Drug Delivery Business News
Thu, 07/13/17 - 09:23 pm
Sunovion
asthma
Covis Pharma
Alvesco
Omnaris